Guideline for designing microbiome studies in neoplastic diseases

Mikó, Edit; Sipos, Adrienn; Tóth, Emese; Lehoczki, Andrea; Fekete, Monika; Sebő, Éva; Kardos, Gábor; Bai, Péter

doi:10.1007/s11357-024-01255-4

Guideline for designing microbiome studies in neoplastic diseases

detalle del documento

IDENTIFICACIÓN

doi:10.1007/s11357-024-01255-4...

Autor

Mikó, Edit Sipos, Adrienn Tóth, Emese Lehoczki, Andrea Fekete, Monika Sebő, Éva Kardos, Gábor Bai, Péter

Langue

Editor

Springer

Categoría

Life Sciences

Año

2024

fecha de cotización

3/7/2024

Palabras clave

cancer microbiome guideline stage grade molecular subtype aging age review microbiome

Métrico

Resumen

Oncobiosis has emerged as a key contributor to the development, and modulator of the treatment efficacy of cancer.

Hereby, we review the modalities through which the oncobiome can support the progression of tumors, and the emerging therapeutic opportunities they present.

The review highlights the inherent challenges and limitations faced in sampling and accurately characterizing oncobiome.

Additionally, the review underscores the critical need for the standardization of microbial analysis techniques and the consistent reporting of microbiome data.

We provide a suggested metadata set that should accompany microbiome datasets from oncological settings so that studies remain comparable and decipherable.

Mikó, Edit,Sipos, Adrienn,Tóth, Emese,Lehoczki, Andrea,Fekete, Monika,Sebő, Éva,Kardos, Gábor,Bai, Péter, 2024, Guideline for designing microbiome studies in neoplastic diseases, Springer